首页> 外文期刊>Cancer control : >The long-term outcome of the Kasai operation in patients with biliary atresia: a systematic review
【24h】

The long-term outcome of the Kasai operation in patients with biliary atresia: a systematic review

机译:胆道腹部患者Kasai手术的长期结果:系统审查

获取原文
           

摘要

Background: Biliary atresia (BA) is a progressive inflammatory destructive process of the bile ducts occurring in about one of every 20,000 live births. If left untreated, biliary atresia can lead to liver failure. The only effective treatments for BA at the moment are the Kasai operation and liver transplantation. Kasai portoenterostomy increases the survival of children with BA and postpones subsequent liver transplantation. Because long-term survival is rare, there is not much known about the long-term efficacy of the Kasai operation. Methods: The aim of this review was to study the outcome of patients with BA who survived more than 20 years on their native liver. We performed a systematic search on PubMed using MeSH terms for articles describing the long-term outcomes of patients with biliary atresia. We searched for patients who have lived at least 20 years with their native liver and we registered the number of complications. The endpoints identified in these articles were: death, cholangitis, portal hypertension and gastrointestinal bleeding. Results: From 53 articles we included 14 articles for analysis. In total 184 patients were above the age of 20 years. Of these 162 patients, 88% (162/184) were still alive with their native liver and 60.5% (98/162) were suffering from liver-related complications. Conclusions: It is possible for patients with biliary atresia to survive more than 20 years on their native liver after undergoing the Kasai operation during early infancy. However, 60.5% of the long-term survivors alive on their native liver end up suffering from progressive liver-related complications.
机译:背景:胆道闭锁(BA)是在每20,000个活产的胆管中发生的胆管发生的渐进炎症性破坏过程。如果留下未经处理的,胆道休息会导致肝脏衰竭。目前唯一有效的BA治疗是Kasai操作和肝移植。 Kasai Portoenterostomy增加了BA和产后的儿童的存活率随后的肝移植。因为长期存活率很少,所以关于Kasai操作的长期疗效并不多。方法:本综述的目的是研究患者患者的患者在其原生肝脏上生存20多年。我们在PubMed中使用了Mesh术语进行了系统搜索,用于描述胆道腹部患者的长期结果。我们搜索了至少20年与其本土肝脏的患者,并注册了并发症的数量。这些文章中鉴定的终点是:死亡,胆管炎,门静脉高压和胃肠道出血。结果:53文章我们包括14篇用于分析。总共184名患者高于20岁以上。在这162名患者中,88%(162/184)仍然存在于他们的本地肝脏,60.5%(98/162)患有肝相关的并发症。结论:在早期婴儿期间发生喀赛伊业务后,胆道闭锁患者可能在其天然肝脏上存活超过20年。然而,60.5%的长期幸存者在其原生肝脏上活着最终患有渐进性肝相关的并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号